missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ RARB Recombinant Rabbit Monoclonal Antibody (24GB1045)

Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA557688
This item is not returnable.
View return policy
Description
RARB Recombinant Monoclonal Antibody for Western Blot, ICC/IF, Flow
Retinoic Acid (RA; active metabolite of vitamin A) plays a prominent role in regulating the transition of proliferating precursor cells (such as carcinoma cells and neuronal precursors) to postmitotic differentiated cells. The Retinoid X Receptors (RXRs) family (RXR alpha, beta, and gamma), preferentially bind 9-cis -RA and regulate gene transcription by forming heterodimers with a second family of RA receptors. RAs have been suggested to potentially play a therapeutic role in cervical cancer. RAs are known to play key roles in neuronal development and an increasing body of evidence indicates that retinoid signaling may regulate synaptic plasticity and associated learning and memory behaviors.
Specifications
| RARB | |
| Recombinant Monoclonal | |
| 1.2 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P10826 | |
| RARB | |
| A synthesized peptide derived from human Retinoic Acid Receptor beta (aa 400-455). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Flow Cytometry, Western Blot, Immunocytochemistry | |
| 24GB1045 | |
| Unconjugated | |
| RARB | |
| A830025K23; HAP; HBV-activated protein; hepatitis B virus activated protein; MCOPS12; NR1B2; nuclear receptor subfamily 1 group B member 2; RAR beta; Rarb; RAR-b; RAR-beta; RARbeta1; RAR-Beta2; RAR-Beta4; RAR-epsilon; retinoic acid; retinoic acid receptor; retinoic acid receptor beta; retinoic acid receptor, beta; retinoic acid receptor, beta polypeptide; RRB2 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 5915 | |
| -20°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction